Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26382004 | 0.87 | AHCY (0.59) | AHCYADORA3 | |
| SCHEMBL12281124 | 0.86 | AHCY (1.00) | AHCYADORA3 | |
| SCHEMBL26382111 | 0.86 | AHCY (1.00) | AHCYADORA3 | |
| Hydrochloric Acid SCHEMBL1935723 | 0.85 | AHCY (0.97) | AHCYADORA3 | |
| SCHEMBL26382003 | 0.71 | AHCY (0.71) | AHCYADORA3 | |
| SCHEMBL26381995 | 0.71 | AHCY (0.71) | AHCYADORA3 | |
| SCHEMBL2049339 | 0.70 | ADORA3 (0.70) | AHCYADORA3 | |
| SCHEMBL18137740 | 0.70 | ADORA3 (0.73) | AHCYADORA3 | |
| SCHEMBL20419152 | 0.70 | ADORA3 (0.69) | AHCYADORA3 | |
| SCHEMBL2050691 | 0.70 | ADORA3 (0.70) | AHCYADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230302003-A1 | COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION | ANTIRNA INCORPORATED | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302003-A1 | COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION | AHCY, AHCYL1, BHMT | AHCY 1/4885ADORA3 931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.